COVID-19 Information
Students who test positive for COVID-19 will be asked to wear a mask if symptomatic and stay away from others until at least 24 hours after both their symptoms are getting better overall, and they have not had a fever (and are not using fever-reducing medication). The RIDOH also has additional information regarding isolation guidelines.
Updated Guidance: The updated Respiratory Virus Guidance recommends that people stay home and away from others until at least 24 hours after both their symptoms are getting better overall, and they have not had a fever (and are not using fever-reducing medication). Note that depending on the length of symptoms, this period could be shorter, the same, or longer than the previous guidance for COVID-19.
It is important to note that the guidance doesn’t end with staying home and away from others when sick. The guidance encourages added precaution over the next five days after time at home, away from others, is over. Since some people remain contagious beyond the “stay-at-home” period, a period of added precaution using prevention strategies, such as taking more steps for cleaner air, enhancing hygiene practices, wearing a well-fitting mask, keeping a distance from others, and/or getting tested for respiratory viruses can lower the chance of spreading respiratory viruses to others.
At-home test kits
At-home test kits are available for no cost at Health Services for students at the URI Pharmacy. If you are not feeling well, please be sure to put a mask on as you enter the building and proceed to the pharmacy. One test per student with student ID.
Free at-home COVID-19 tests from the government are no longer available.
Faculty and staff who are symptomatic and/or exposed can contact their primary care provider or visit an urgent care center. Staff and faculty members who test positive for the COVID-19 virus should notify their supervisors. Faculty and staff should also notify their primary care providers, particularly if they are immunocompromised or at risk for severe disease, to determine whether they are candidates for antiviral medication.